Belgium's Cardio3 plans U.S. share listing
April 01, 2015 at 03:18 AM EDT
BRUSSELS, April 1 (Reuters) - Belgian cell therapy company Cardio3 BioSciences said late on Tuesday that it planned to seek an additional listing in the United States.
